Jocelyn Gal

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Esma Saâda-Bouzid, Cécile Defaucheux, Andy Karabajakian et al. · Annals of Oncology · 2017 · 596 citations

Oncology, Neoadjuvant Therapy, Anti-pd-1/pd-l1 Therapy +6

Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: Multicentric study of the GEC-ESTRO Breast Cancer Working Group

Jean‐Michel Hannoun‐Lévi, Alexandra Resch, Jocelyn Gal et al. · Radiotherapy and Oncology · 2013 · 154 citations

Surgical Oncology, Radiation Medicine, Breast Oncology +11

Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome

J. Doyen, C. Trastour, F. Ettore et al. · Biochemical and Biophysical Research Communications · 2014 · 110 citations · Full text

Tumor Biology, Breast Oncology, Medicine +10

Unconjugated bisphenol A cord blood levels in boys with descended or undescended testes

Patrick Fénichel, H. Déchaux, C. Harthé et al. · Human Reproduction · 2012 · 104 citations

Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas

Esma Saâda-Bouzid, Fanny Burel‐Vandenbos, Dominique Ranchère‐Vince et al. · Modern Pathology · 2015 · 100 citations · Full text

Tumoral Pathology, Malignant Disease, Medicine +9